GeneSight MTHFR is a laboratory developed test that analyzes one important gene to help predict how your body may convert folic acid into its active form. Folic acid must be in its active form for your body to use it. This information can help your healthcare provider decide if you would benefit from taking an additional folic acid supplement.
Not being able to convert folic acid into its active form can cause a folic acid (folate) deficiency. It can be important to know of a folic acid deficiency when treating depression, anxiety, cardiovascular disease, or when pregnant. With GeneSight, your healthcare provider has information to take an individualized approach to prescribing folic acid supplements for you if needed.
GeneSight is based on pharmacogenomics—the study of how genes affect a person’s response to medicines. This test was developed in the Assurex Health clinical laboratory and is based on patented technology licensed from two world renowned medical centers, Mayo Clinic and Cincinnati Children’s Hospital Medical Center, who continue to be research collaborators.